Targeting Base Excision Repair in Cancer: NQO1-Bioactivatable Drugs Improve Tumor Selectivity and Reduce Treatment Toxicity Through Radiosensitization of Human Cancer

Ionizing radiation (IR) creates lethal DNA damage that can effectively kill tumor cells. However, the high dose required for a therapeutic outcome also damages healthy tissue. Thus, a therapeutic strategy with predictive biomarkers to enhance the beneficial effects of IR allowing a dose reduction wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Starcher, Colton L., Pay, S. Louise, Singh, Naveen, Yeh, I-Ju, Bhandare, Snehal B., Su, Xiaolin, Huang, Xiumei, Bey, Erik A., Motea, Edward A., Boothman, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468503/
https://www.ncbi.nlm.nih.gov/pubmed/32974194
http://dx.doi.org/10.3389/fonc.2020.01575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468503/
https://www.ncbi.nlm.nih.gov/pubmed/32974194
http://dx.doi.org/10.3389/fonc.2020.01575

Ejemplares similares